Simplex Trading
BLCM

Simplex Trading’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Simplex Trading’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,550
Closed -$1.15M – 8752
2020
Q2 		$1.15M Hold
1,550
– – ﹤0.01% 2016
2020
Q1 		$730K Buy
1,550
+1,498
+2,881% +$16.1K ﹤0.01% 2196
2019
Q4 		$66K Sell
52
-36
-41% -$332 ﹤0.01% 4948
2019
Q3 		$91K Buy
88
+82
+1,367% +$1.07K ﹤0.01% 4429
2019
Q2 		$9K Sell
6
-4
-40% -$108 ﹤0.01% 6191
2019
Q1 		$33K Buy
10
+8
+400% +$267 ﹤0.01% 5346
2018
Q4 		$4K Sell
2
-3
-60% -$133 ﹤0.01% 6359
2018
Q3 		$32K Sell
5
-5
-50% -$338 ﹤0.01% 5601
2018
Q2 		$76K Sell
10
-2
-17% -$156 ﹤0.01% 4612
2018
Q1 		$2K Sell
12
-5
-29% -$378 ﹤0.01% 5403
2017
Q4 		$21K Sell
17
-14
-45% -$1.37K ﹤0.01% 3276
2017
Q3 		$92K Sell
31
-2
-6% -$210 ﹤0.01% 1786
2017
Q2 		$19K Buy
+33
New +$4.1K ﹤0.01% 3365
2016
Q1 		– Sell
-18
Closed -$10K – 6445
2015
Q4 		$10K Buy
18
+16
+800% +$2.86K ﹤0.01% 3326
2015
Q3 		$3K Sell
2
-6
-75% -$1.1K ﹤0.01% 4458
2015
Q2 		$18K Buy
+8
New +$1.96K ﹤0.01% 2576

Other funds holding BLCM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Simplex Trading's BLCM Position: Q3 2019 in Review

Simplex Trading sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q3 2019, closing a stake of 4,103 shares — an estimated $53.6K sold.

Simplex Trading first reported a position in BLCM in Q4 2015 and held it in 14 quarters. The position peaked at $342K in Q3 2016. 67 funds tracked by Wall St. Rank hold BLCM as of Q3 2019.

  • Simplex Trading reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
  • Simplex Trading sold 4,103 Bellicum Pharmaceuticals, Inc. shares in Q3 2019, an estimated $53.6K.
  • Simplex Trading first reported a position in Bellicum Pharmaceuticals, Inc. in Q4 2015 and held it in 14 quarters.
  • Simplex Trading's Bellicum Pharmaceuticals, Inc. position peaked at $342K in Q3 2016.
  • 67 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q3 2019.

Based on Simplex Trading's 13F filing for Q3 2019, filed 15 Oct 2019.